What is the workup for a 31-year-old male (YOM) with non-pulsatile tinnitus and no hearing loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 31-year-old male with non-pulsatile tinnitus and no hearing loss, I recommend a comprehensive workup starting with a detailed history and physical examination, focusing on potential causes such as noise exposure, ototoxic medications, and temporomandibular joint dysfunction, as suggested by the American Academy of Otolaryngology and Head and Neck Surgery Foundation guidelines 1. The initial evaluation should include a complete audiological assessment with pure tone audiometry, speech audiometry, tympanometry, and otoacoustic emissions to confirm normal hearing and rule out subtle auditory abnormalities. Some key points to consider in the workup include:

  • Laboratory tests should include complete blood count, thyroid function tests, lipid profile, and fasting blood glucose to identify metabolic causes.
  • Imaging studies are not routinely needed for non-pulsatile tinnitus with normal hearing but may include MRI of the brain and internal auditory canals if neurological symptoms are present or if tinnitus is unilateral and persistent, as recommended by the ACR Appropriateness Criteria 1.
  • Referral to otolaryngology is appropriate for specialized assessment. Management typically involves addressing any identified underlying causes, counseling about tinnitus, sound therapy with white noise generators or hearing aids if beneficial, and cognitive behavioral therapy for coping strategies, as recommended by the American Academy of Otolaryngology and Head and Neck Surgery Foundation guidelines 1. Tinnitus often results from neural hyperactivity in auditory pathways despite normal peripheral hearing, which explains why patients can experience tinnitus even with normal audiograms. Given the most recent evidence from 2023, imaging studies such as MRI of the brain and internal auditory canals should only be considered if there are neurological symptoms or if the tinnitus is unilateral and persistent 1. It is essential to follow the guidelines and recommendations from reputable sources, such as the American Academy of Otolaryngology and Head and Neck Surgery Foundation and the American College of Radiology, to ensure the best possible outcome for the patient 1.

From the Research

Workup for Non-Pulsatile Tinnitus with No Hearing Loss

  • A standard workup for tinnitus begins with a targeted history and physical examination to identify treatable causes and associated symptoms that may improve with treatment 2.
  • Less common but potentially dangerous causes such as vascular tumors and vestibular schwannoma should be ruled out 2.
  • A comprehensive audiologic evaluation is not necessarily required for patients with non-pulsatile tinnitus and no hearing loss, unless the tinnitus is unilateral, has been present for six months or longer, or is accompanied by other symptoms 2.
  • Neuroimaging is not part of the standard workup for non-pulsatile tinnitus with no hearing loss, unless there are other symptoms such as focal neurologic abnormalities or asymmetric hearing loss 2, 3.

Consideration of Venous Origin

  • Non-pulsatile subjective tinnitus without hearing loss may be caused by undetectable sounds originating from the venous system of the brain 4.
  • The dural-jugular system is dominant only in the horizontal body position, and jugular flow is at maximum during this position, possibly making any noise generated within the dural-jugular system louder 4.
  • If a vascular pathology causes a non-pulsatile complaint that cannot be heard by the examiner or cannot be detected clinically or radiologically, it is bound to be misdiagnosed as central tinnitus 4.

Imaging Studies

  • Imaging studies should only be performed after a careful clinical examination and otoscopy 5.
  • The choice of imaging study should be guided by the type of hearing loss and additional physical examination findings 3.
  • Magnetic resonance imaging of the internal auditory meatus is the definitive investigation in the detection of vestibular schwannomas, but the detection rate of vestibular schwannoma in patients with unilateral non-pulsatile tinnitus without asymmetrical hearing loss is low 6.

References

Related Questions

Is an MRI normally indicated for unilateral high-frequency hearing loss with bilateral tinnitus?
How to manage a 19-year-old male with bilateral tinnitus, taking Remicade (Infliximab) and Hydroxyzine, presenting with tachycardia and hypotension?
What technique would most likely help normalize sympathetic tone in a patient with tinnitus?
What is the recommended treatment for an elderly patient with dizziness, tinnitus (ringing in the ear), and ear pain for 3 weeks?
What are the appropriate tests and treatment plan for a patient experiencing tinnitus (ringing in the ears) and dizziness one week after attending a concert?
What is the diagnosis for a 19-year-old female presenting with a history of vaginal itching and irritation, which have since resolved, and reporting a recent unprotected sexual encounter in April, currently experiencing menstruation, and having passed a tissue-like fragment, while using the Depo (medroxyprogesterone) injection for contraception?
What is the role of topical corticosteroid (steroid) cream in the treatment of chronic urticaria?
What are the indications for computed tomography (CT) of the head in cases of traumatic brain injury (TBI)?
What is the role of inhalation therapy in patients with Chronic Obstructive Pulmonary Disease (COPD) using the Edmonton (Escala Eden) protocol?
What is the potential interaction between the patient's current medications, including Aripiprazole (Abilify) (Aripiprazole), Atorvastatin (Lipitor) (Atorvastatin), Buspirone (Buspar) (Buspirone), Desvenlafaxine (Pristiq) (Desvenlafaxine), Dextroamphetamine-Amphetamine (Adderall) (Dextroamphetamine-Amphetamine), Haloperidol (Haldol) (Haloperidol), Lamotrigine (Lamictal) (Lamotrigine), Lisinopril (Prinivil, Zestril) (Lisinopril), Metformin (Glucophage) (Metformin), Omeprazole (Prilosec) (Omeprazole), Ondansetron (Zofran) (Ondansetron), Potassium Chloride (K-Dur, Klor-Con) (Potassium Chloride), and Sumatriptan (Imitrex) (Sumatriptan)?
What are the most commonly compounded dermatological medications in the United States of America (USA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.